Viewing Study NCT04599634


Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2025-12-31 @ 8:34 PM
Study NCT ID: NCT04599634
Status: COMPLETED
Last Update Posted: 2025-02-04
First Post: 2020-10-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Venetoclax With Obinutuzumab and Magrolimab (VENOM) in Relapsed and Refractory Indolent B-cell Malignancies
Sponsor: National Cancer Institute (NCI)
Organization: